CiceroDx, Inc. is a diagnostics company dedicated to the advancement of clinical assays for understudied diseases.
Endometriosis is a major focus of CiceroDx, now offering for the first time a global test for all stages of endometriosis. This disease affects over 176 million women and takes 11 years on average to diagnose. Many women spend years dealing with pain, infertility and bowel or bladder symptoms without knowing that endometriosis is the cause.
CiceroDx, Inc. is the exclusive licensed provider for BCL6 analysis on endometrial tissue.